Prosecution Insights
Last updated: July 17, 2026
Application No. 19/037,101

STEERABLE CATHETER ASSEMBLIES

Non-Final OA §102
Filed
Jan 25, 2025
Priority
Jan 26, 2024 — provisional 63/625,779 +2 more
Examiner
GEDEON, BRIAN T
Art Unit
Tech Center
Assignee
Abiomed Inc.
OA Round
1 (Non-Final)
87%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allowance Rate
1182 granted / 1354 resolved
+27.3% vs TC avg
Moderate +7% lift
Without
With
+7.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
38 currently pending
Career history
1387
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
48.8%
+8.8% vs TC avg
§102
7.8%
-32.2% vs TC avg
§112
1.3%
-38.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1354 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 2, 4, 5, 8, 10, and 17 are is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Corbett et al. (WO 2017/210318 – disclosed by Applicant). In regard to claim 1, Corbett et al. disclose an intracardiac blood pump system comprising: a blood pump comprising a proximal portion and a distal portion (para 80, figure 3, pump 300 with distal portion 306, and proximal portion 308); a catheter coupled to the proximal portion of the blood pump (para 70, a catheter is connected to the cannula of a blood pump; para 81, proximal portion 308 connected to catheter 303 at transition portion 309), the catheter having a proximal end and a distal end and an inner lumen extending from the proximal end to the distal end (figure 3 shows the catheter 303 with a proximal portion 311, and is considered to implicitly include a distal portion and lumen); a rotatable shaft including a proximal end and a distal end, wherein the shaft extends through the inner lumen of the catheter and the distal end of the shaft is coupled to the proximal portion of the blood pump (para 5, 71, cannula of blood pump is rotatable relative to catheter; para 78, the catheter includes a shaft used to position in the cannula of the blood pump in the target location); and a steering mechanism coupled to a portion of the shaft, wherein the steering mechanism is configured to rotate the shaft to rotate the blood pump (para 21, 30, and 78). In regard to claim 2, in Corbett et al. the steering mechanism is proximal of the catheter (para 21, 30, and 78). In regard to claim 4, in Corbett et al., the steering mechanism comprises: a torque input mechanism; and a torque transfer mechanism configured to transfer torque inputted to the torque input mechanism to the shaft to rotate the shaft (para 76, a handle is coupled to the catheter assembly is rotated relative to the catheter assembly or one or more components of the catheter assembly; in this manner the handle applies and transfers a rotational force (i.e., torque) on the catheter). In regard to claim 5, in Corbett et al. the torque input mechanism comprises a component that is manually rotatable by a user (para 76, the handle is exterior and is considered capable of manually rotated). In regard to claim 8, in Corbett et al. the shaft comprises a lumen extending from the proximal end to the distal end of the shaft (para 5, 71, cannula of blood pump is rotatable relative to catheter; para 78, the catheter includes a shaft used to position in the cannula of the blood pump in the target location). In regard to claim 10, in Corbett et al. further comprises a coupling mechanism configured to rotatably couple the proximal portion of the blood pump to the distal end of the catheter (para 70, a catheter and blood pump cannula connected thereto, wherein the state of being coupled implies a coupling mechanism; para 116 may include one or more additional intermediate members being used to attach one another, such additional intermediate member considered to be a coupling mechanism). In regard to claim 17, Corbett et al. disclose an intracardiac blood pump system comprising: a blood pump comprising a proximal portion and a distal portion (para 80, figure 3, pump 300 with distal portion 306, and proximal portion 308); a catheter coupled to the proximal portion of the blood pump (para 70, a catheter is connected to the cannula of a blood pump; para 81, proximal portion 308 connected to catheter 303 at transition portion 309), the catheter having a proximal end and a distal end and an inner lumen extending from the proximal end to the distal end (figure 3 shows the catheter 303 with a proximal portion 311, and is considered to implicitly include a distal portion and lumen); and a coupling mechanism configured to rotationally couple the proximal portion of the blood pump to the distal end of the catheter (para 70, a catheter and blood pump cannula connected thereto, wherein the state of being coupled implies a coupling mechanism; para 116 may include one or more additional intermediate members being used to attach one another, such additional intermediate member considered to be a coupling mechanism). Allowable Subject Matter Claims 26-28 are allowed. The following is an examiner’s statement of reasons for allowance: the prior art fails to teach the structural features of the steering mechanism. Claims 3, 6, 7, 9, 11-16, and 18-25 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The prior art fails to teach or suggest the claimed elements in combination with the elements of the base claim. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIAN T GEDEON whose telephone number is (571)272-3447. The examiner can normally be reached M-F 8:00 am to 5:30 PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David E. Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRIAN T GEDEON/Primary Examiner, Art Unit 3796 26 June 2026
Read full office action

Prosecution Timeline

Jan 25, 2025
Application Filed
Jul 01, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678623
SYSTEM AND METHOD TO SELECT AMONG TRAJECTORIES FOR THERAPEUTIC STIMULATION OF A TARGET VOLUME REGION WITHIN THE BRAIN
2y 9m to grant Granted Jul 14, 2026
Patent 12678098
FINGER WEARABLE HEALTH MONITORING DEVICE
3y 0m to grant Granted Jul 14, 2026
Patent 12678232
SURGICAL SYSTEM
2y 9m to grant Granted Jul 14, 2026
Patent 12673204
Cochlear Implant System Using Compatible External Device
2y 9m to grant Granted Jul 07, 2026
Patent 12667730
METHOD AND DEVICE FOR CONTROLLING CARDIAC RESYNCHRONIZATION THERAPY BASED ON HEART SOUNDS
2y 8m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
87%
Grant Probability
94%
With Interview (+7.1%)
2y 6m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1354 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month